Guizhou Sanli Pharmaceutical Co., Ltd. logo

Guizhou Sanli Pharmaceutical Co., Ltd. (603439)

Market Closed
11 Aug, 06:57
SSE SSE
¥
12. 65
+0.93
+7.9352%
¥
5.16B Market Cap
- P/E Ratio
0.8% Div Yield
26.21M Volume
- Eps
¥ 11.72
Previous Close
Add Transaction
Day Range
11.3 12.89
Year Range
9.51 17.46
Want to track 603439 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Guizhou Sanli Pharmaceutical Co., Ltd. logo
603439 Guizhou Sanli Pharmaceutical Co., Ltd.
16 May 2025
-
-
Guizhou Sanli Pharmaceutical Co., Ltd. logo
603439 Guizhou Sanli Pharmaceutical Co., Ltd.
28 Oct 2024
-
-
Guizhou Sanli Pharmaceutical Co., Ltd. logo
603439 Guizhou Sanli Pharmaceutical Co., Ltd.
26 Apr 2024
-
-
Guizhou Sanli Pharmaceutical Co., Ltd. logo
603439 Guizhou Sanli Pharmaceutical Co., Ltd.
27 Oct 2023
-
-

603439 Earnings Reports FAQ

What is the earnings per share (EPS) for 603439?

EPS data for 603439 is currently not available, as Guizhou Sanli Pharmaceutical Co., Ltd has not reported recent earnings.

What is the company's earnings growth rate?

Guizhou Sanli Pharmaceutical Co., Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Guizhou Sanli Pharmaceutical Co., Ltd has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Guizhou Sanli Pharmaceutical Co., Ltd are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 603439 at this time, as Guizhou Sanli Pharmaceutical Co., Ltd has no recent EPS data to calculate it.